1. A pharmacokinetic model for high-dose methotrexate infusions in man

   • Steven D. Reich
   • Nicholas R. Bachur
   • Mones Berman

   OriginalPaper 17 July 2015 Pages: 421 - 433

2. Pharmacokinetics of propylthiouracil in man after intravenous infusion

   • Jens P. Kampmann

   OriginalPaper 17 July 2015 Pages: 435 - 443

3. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

   • Lewis B. Sheiner
   • Barr Rosenberg
   • Vinay V. Marathe

   OriginalPaper 17 July 2015 Pages: 445 - 479

4. Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects

   • F. B. Eatman
   • W. A. Colburn
   • S. A. Kaplan

   OriginalPaper 17 July 2015 Pages: 481 - 494

5. Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin

   • Thorir D. Bjornsson
   • Peter J. Meffin
   • Terrence F. Blaschke

   OriginalPaper 17 July 2015 Pages: 495 - 505

6. Influence of phenobarbital on the disposition of clonazepam and antipyrine in the dog

   • I. Bekersky
   • A. C. Maggio
   • S. A. Kaplan

   OriginalPaper 17 July 2015 Pages: 507 - 512

7. Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT

   • Peter Veng Pedersen

   OriginalPaper 17 July 2015 Pages: 513 - 531

8. Bioavailability assessment: Methods to estimate total area (AUC 0-∞) and total amount excreted (A _e ^∞ ) and importance of blood and urine sampling scheme with application to digoxin

   • John G. Wagner
   • James W. Ayres

   OriginalPaper 17 July 2015 Pages: 533 - 557